Literature DB >> 10369152

Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients--results of a 2-year follow-up.

S Klingberg1, G Buchkremer, R Holle, H Schulze Mönking, W P Hornung.   

Abstract

There is increasing evidence of the efficacy and effectiveness of psychosocial interventions in schizophrenic patients. However, little research has been done on differential therapy effects. In a prospective, randomized clinical trial we carried out psychoeducational medication management training, cognitive psychotherapy, and key-person counseling. The patients of the control group participated in structured free-time activities for control of therapeutic commitment. Data from a total of 156 schizophrenic patients (DSM-III-R, no first-admissions) were available at 2-year follow-up. We analyzed in this study whether there are differential therapy effects of these interventions, depending on patient characteristics at baseline. There was a significant statistical interaction between treatment condition (specific/non-specific) and prognosis with respect to treatment outcome. Patients with a favorable prognosis and better social functioning had a better course under the specific treatment but a less favorable outcome in the non-specifically treated control group. These results suggest that more vulnerable patients are not sufficiently capable of learning and using coping strategies for relapse prevention. We need to learn more about differential indications for psychosocial treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10369152     DOI: 10.1007/s004060050068

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  11 in total

Review 1.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

Review 2.  Psychoeducation for schizophrenia.

Authors:  Jun Xia; Lars Bertil Merinder; Madhvi R Belgamwar
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 3.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 4.  [Evidence basis of psychotherapy for schizophrenia patients in Germany].

Authors:  B Puschner; R Vauth; F Jacobi; T Becker
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

Review 5.  Distraction techniques for schizophrenia.

Authors:  C J Crawford-Walker; A King; S Chan
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 6.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

Review 7.  Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.

Authors:  Christopher Jones; David Hacker; Irene Cormac; Alan Meaden; Claire B Irving
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Cognitive behavioural therapy (group) for schizophrenia.

Authors:  Giuseppe Guaiana; Massimiliano Abbatecola; Ghazaleh Aali; Federica Tarantino; Ikenna D Ebuenyi; Valeria Lucarini; Wei Li; Caidi Zhang; Antonio Pinto
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12

9.  Effectiveness of a psycho-educational intervention for reducing burden in Latin American families of patients with schizophrenia.

Authors:  José Gutiérrez-Maldonado; Alejandra Caqueo-Urízar
Journal:  Qual Life Res       Date:  2007-02-08       Impact factor: 3.440

10.  Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Alan Meaden; Irene Cormac; Claire B Irving; Jun Xia; Sai Zhao; Chunhu Shi; Jue Chen
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.